MYO 75mg Tablet

MYO 75mg Tablet is an antiplatelet medicine or a blood thinner that helps to prevent the formation of harmful blood clots in your blood vessels. This helps to lower the chances of you getting a heart attack or stroke. It is a widely used medicine for heart protection.

MYO 75mg Tablet is prescribed to people at high risk of heart disease. This includes people with peripheral vascular disease (blood circulation problems due to narrowing of blood vessels), recent heart attack or stroke, irregular heartbeats, and those who have undergone certain heart procedures like stenting. It is also used in combination with some other medicines for the treatment of heart attack and some types of heart-related chest pain (unstable angina).

This medicine may be taken with or without food and should be taken at the same time each day. It is important to keep taking this medicine even if you feel well. If you stop taking this medicine, it may increase your chance of having a heart attack or stroke.

The most common side effect seen with this medicine is bleeding. This may be in the form of bruising, nose bleeds, blood in urine or stools (black-colored stools), or heavier periods than usual in women. If you cut or injure yourself, it may take longer than usual for the bleeding to stop. Such episodes of bleeding are usually mild and resolve on their own. However, you should consult your doctor straight away if the bleeding persists or worries you.

This medicine is not suitable for some people. Do not take it if you are bleeding from anywhere in the body such as a stomach ulcer or bleeding within the brain. Before taking it, you should let your doctor know if you have ever had a problem with your blood not clotting properly or if you have recently had a serious injury or surgery. This medicine may need to be stopped temporarily before planned surgery or dental treatment.

• Prevention of heart attack and stroke

Prevention of heart attack and stroke
MYO 75mg Tablet is an antiplatelet medicine, or blood thinner. It works by preventing cells called platelets from sticking together and helps to prevent your blood from clotting inside veins and arteries. This helps the blood flow freely around your body thereby preventing a heart attack or stroke (or deep vein thrombosis or pulmonary embolism). Take this medicine regularly and make appropriate lifestyle changes to achieve maximum benefits. It is often prescribed along with a low dose of aspirin which also helps to prevent blood from clotting.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of T Clop

• Bleeding

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. MYO 75mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

MYO 75mg Tablet is an antiplatelet medication. It works by preventing platelets from sticking together, thereby decreasing the formation of harmful blood clots. This lowers the chance of heart attack or stroke.

• For best results, take it at the same time every day.
• MYO 75mg Tablet increases your risk of bleeding. Be careful while shaving, using sharp objects, or cutting fingernails or toenails.
• Do not discontinue using the medicine without consulting your doctor as this may increase your chances of having another heart attack or stroke.
• If you are scheduled to undergo a surgery or dental treatment, you may be asked to stop taking MYO 75mg Tablet temporarily.

Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 869-70.

Zehnder JL. Drugs Used in Disorders of Coagulation. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 598-99.

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 304-305.

Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 245-48.

Clopidogrel hydrogen sulfate. North Harrow, Middlesex; Accord Healthcare Limited; 2010 [revised 05 Jun. 2018]. [Accessed 25 Jan. 2019] (online) Available from:

Clopidogrel bisulfate. New York, New York: Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership; 2006. [Accessed 15 Mar. 2019] (online) Available from:

Central Drugs Standard Control Organisation (CDSCO). Clopidogrel. [Accessed 15 Mar. 2019] (online) Available from: